Perfil clínico de los pacientes ingresados al programa EPOC en un consultorio de atención primaria durante 10 años

Alvear T, Gonzalo; Figueroa R, Lidia P; Peña M, Carlos.
Rev. chil. enferm. respir ; 31(1): 17-26, mar. 2015. graf, tab
Artigo em Espanhol | LILACS | ID: lil-747510

Documentos relacionados

  1. The different phenotypes of COPD.
  2. p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics.
  3. Macrophages-the immune effector guardians of the lung: impact of corticosteroids on their functional responses.
  4. [Progress in pre-chronic obstructive pulmonary disease].
  5. Diagnoses and prescription patterns among users of medications for obstructive airway diseases in Finland.
  6. [The GOLD (Global Initiative for Chronic Obstructive Lung Disease) 2023 : a substantial revision].
  7. Treatment patterns and cost of exacerbations in patients with chronic obstructive pulmonary disease using multiple inhaler triple therapy in South Korea.
  8. Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD 'real world' study.
  9. The impact of impaired sleep quality on symptom change and future exacerbation of chronic obstructive pulmonary disease.
  10. In 'real world' patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations.